Genesis AI Launches GENE-26.5 Robotics Platform With US$105M Funding

Genesis AI launched GENE-26.5 on May 6, a full-stack robotics platform designed to improve robot manipulation using data from a proprietary hand glove, simulation, and human videos, according to the company. The startup has raised US$105 million from investors including Eclipse and Khosla Ventures and plans to deploy its system in workplace settings.

Product and Technology

Genesis AI demonstrated robots performing cooking tasks and laboratory work using the new platform. The system uses a data-capture glove that mirrors human hand movements to train the AI model. The company built the entire stack in-house, including the AI model, a proprietary dexterous hand, a data-capture glove, and a simulator.

According to the company, the Genesis Hand 1.0 matches human hand size to enable near-lossless transfer of human demonstrations to robot movements, reducing the need for complex software translation. The company also developed its own control software, reporting that tracking error decreased from approximately 20 millimeters to approximately 2 millimeters compared with the robot arm supplier's default controller.

Market Context

Genesis AI enters a competitive robotics market with 27 active rivals. U.S. industrial robotics has drawn US$2.57 billion in funding so far in 2026.

Limitations and Verification Gaps

The company did not share third-party benchmarks for GENE-26.5. According to the source, there are currently no verified commercial deployments, named customers, or independent benchmark results available for the platform.

Sim-to-real transfer—the challenge of applying skills learned in simulation to physical robot systems—remains a known risk in contact-rich manipulation tasks. Additionally, the robotics industry lacks specific Occupational Safety and Health Administration (OSHA) standards, leaving open questions about safety when humanoid robots operate near people.